INDIANAPOLIS (AP) -- European regulators approved the use of an imaging agent from Eli Lilly, which can help doctors diagnose Alzheimer's disease. The Indianapolis drugmaker plans to make Amyvid ...
Amyvid™ (Florbetapir F 18 Injection) Approved in European Union for Use in Patients With Cognitive Impairment Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Impairment ...
INDIANAPOLIS, Oct. 19, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced they received a positive opinion ...
INDIANAPOLIS, Oct. 19, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced they received a positive opinion ...
Last Friday, the FDA approved Amyvid, a drug for Alzheimer’s diagnosis that was created and developed by Penn faculty Daniel Skovronsky and Hank Kung. It dyes brain deposits of amyloid plaque, which ...
The FDA approval of Amyvid will expand the clinical and research opportunities for amyloid imaging. The Alzheimer's Association has convened a task force with the Society of Nuclear Medicine to ...
Although the Centers for Medicare and Medicaid is not hot on paying for Eli Lilly’s PET scan for all Alzheimer’s disease diagnostics, the scan is playing a pivotal role in the drug maker’s latest ...
"Amyvid is the first and only diagnostic tool approved for use in the European Union that can show the presence or absence of beta-amyloid neuritic plaque density in the brain," said Diane Bakaysa, ...
The Centers for Medicare and Medicaid Services (CMS) is pursuing a National Coverage Determination (NCD) for monoclonal antibodies that clear amyloid beta plaque from the brain, such as aducanumab ...
FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline Amyvid is the first and only radioactive diagnostic ...
INDIANAPOLIS -- A European committee has endorsed the use of Eli Lilly and Co.'s imaging agent Amyvid for helping to diagnose Alzheimer's disease. The Committee for Medicinal Products for Human Use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results